The stock of Ardelyx Inc (NASDAQ: ARDX) has decreased by -7.87 when compared to last closing price of 5.72. Despite this, the company has experienced a -4.87% fall in its stock price over the last five trading sessions. seekingalpha.com reported 2024-11-24 that Ardelyx lost a lawsuit against Medicare, impacting XPHOZAH’s revenue potential, with no other major prospects in its pipeline. CMS’s decision to move XPHOZAH to the bundled payment system significantly reduces its revenue, forcing Ardelyx to negotiate complex reimbursements. The Kidney PATIENT Act, if passed, will delay the inclusion of oral-only ESRD drugs in the bundled payment system, benefiting Ardelyx until 2027.
Is It Worth Investing in Ardelyx Inc (NASDAQ: ARDX) Right Now?
Company’s 36-month beta value is 0.83.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ARDX is 227.84M, and currently, short sellers hold a 10.23% ratio of that floaft. The average trading volume of ARDX on December 10, 2024 was 3.95M shares.
ARDX’s Market Performance
ARDX stock saw a decrease of -4.87% in the past week, with a monthly decline of -17.40% and a quarterly a decrease of -7.38%. The volatility ratio for the week is 7.08%, and the volatility levels for the last 30 days are 7.63% for Ardelyx Inc (ARDX). The simple moving average for the last 20 days is 1.51% for ARDX stock, with a simple moving average of -19.11% for the last 200 days.
Analysts’ Opinion of ARDX
Many brokerage firms have already submitted their reports for ARDX stocks, with H.C. Wainwright repeating the rating for ARDX by listing it as a “Neutral.” The predicted price for ARDX in the upcoming period, according to H.C. Wainwright is $5.50 based on the research report published on November 11, 2024 of the current year 2024.
Piper Sandler, on the other hand, stated in their research note that they expect to see ARDX reach a price target of $7, previously predicting the price at $15. The rating they have provided for ARDX stocks is “Neutral” according to the report published on July 02nd, 2024.
Leerink Partners gave a rating of “Outperform” to ARDX, setting the target price at $14 in the report published on April 05th of the current year.
ARDX Trading at -7.77% from the 50-Day Moving Average
After a stumble in the market that brought ARDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.98% of loss for the given period.
Volatility was left at 7.63%, however, over the last 30 days, the volatility rate increased by 7.08%, as shares surge +3.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.75% lower at present.
During the last 5 trading sessions, ARDX fell by -4.87%, which changed the moving average for the period of 200-days by -39.29% in comparison to the 20-day moving average, which settled at $5.19. In addition, Ardelyx Inc saw -15.00% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ARDX starting from RAAB MICHAEL, who sale 25,000 shares at the price of $5.38 back on Nov 25 ’24. After this action, RAAB MICHAEL now owns 1,150,385 shares of Ardelyx Inc, valued at $134,482 using the latest closing price.
MICHAEL G. RAAB, the Officer of Ardelyx Inc, proposed sale 25,000 shares at $5.38 during a trade that took place back on Nov 25 ’24, which means that MICHAEL G. RAAB is holding shares at $134,480 based on the most recent closing price.
Stock Fundamentals for ARDX
Current profitability levels for the company are sitting at:
- -0.25 for the present operating margin
- 0.85 for the gross margin
The net margin for Ardelyx Inc stands at -0.29. The total capital return value is set at -0.22. Equity return is now at value -41.54, with -22.09 for asset returns.
Based on Ardelyx Inc (ARDX), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at -0.61. The debt to equity ratio resting at 0.65. The interest coverage ratio of the stock is -3.76.
Currently, EBITDA for the company is -55.35 million with net debt to EBITDA at -1.08. When we switch over and look at the enterprise to sales, we see a ratio of 5.18. The receivables turnover for the company is 4.73for trailing twelve months and the total asset turnover is 0.68. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.03.
Conclusion
In a nutshell, Ardelyx Inc (ARDX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
